Evidence map›Paper›PMID 41169497›Full record

ArticleiScience2025

Chronic optogenetic activation of hippocampal CA1 neurons triggers Alzheimer's disease-like proteomic remodeling.

Iason Keramidis, Martina Samiotaki, Romain Sansonetti, Johanna Alonso, Patrick Desrosiers, Katerina Papanikolopoulou, Yves De Koninck

Abstract read
In one paragraph

Article in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Iason KeramidisCervo Brain Research Centre, Quebec Mental Health Institute, Québec, QC, Canada.
Martina SamiotakiInstitute for Bio-Innovation, Biomedical Sciences Research Center Alexander Fleming, Vari, Greece.
Romain SansonettiCervo Brain Research Centre, Quebec Mental Health Institute, Québec, QC, Canada.
Johanna AlonsoCervo Brain Research Centre, Quebec Mental Health Institute, Québec, QC, Canada.
Patrick DesrosiersCervo Brain Research Centre, Quebec Mental Health Institute, Québec, QC, Canada.
Katerina PapanikolopoulouInstitute for Fundamental Biomedical Research, Biomedical Sciences Research Center Alexander Fleming, Vari, Greece.
Yves De KoninckCervo Brain Research Centre, Quebec Mental Health Institute, Québec, QC, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuronal overexcitability triggers synaptic changes, leading to neural hyperactivity, network disruption, and is postulated to trigger neurodegeneration in Alzheimer's disease (AD). However, the sequence of synaptic changes from excessive activity remains unclear. We employed optogenetics to induce sustained neuronal hyperactivity in the hippocampi of wild-type and AD-like 5xFAD mice. After a month of daily optogenetic stimulation, the proteomic profiles of photoactivated wild-type and 5xFAD mice exhibited remarkable similarity. Proteins involved in translation, protein transport, autophagy, and notably in the AD pathology were upregulated in wild-type mice. Conversely, both glutamatergic and GABAergic synaptic proteins were downregulated. These hippocampal proteomic and signaling alterations in wild-type mice resulted in spatial memory loss and augmented Αβ42 secretion. Collectively, these findings indicate that sustained neuronal hyperactivity alone replicates proteome changes seen in AD-like mutant mice. Therefore, prolonged neuronal hyperactivity may contribute to synaptic transmission disruption, memory deficits and the neurodegenerative process associated with AD.

Indexed as

Cellular neuroscienceMolecular neuroscienceProteomics

Identifiers

PMID41169497
PMCPMC12570377

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.